Skip to Main Content

Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumors

Conditions

Bones and Joints | Kidney | Soft Tissue | Pediatrics

Phase III

What is the purpose of this trial?

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumors.

  • Trial with
    Children's Oncology Group (The)
  • Start Date
    01/16/2019
  • End Date
    01/31/2022
Trial Image

For more information about this study, contact:

Sharon Huie

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    01/18/2019
  • Study HIC
    #2000023877